Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
OA03 - Molecular Targeted Treatments
- 14:30 - 15:40
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Andrew Ciupek, David R. Gandara
-
+
Session Moderator
15:32 - 15:40 | Presenter: Andrew Ciupek
- Abstract
Loading... -
+
Session Moderator
15:32 - 15:40 | Presenter: David R. Gandara
- Abstract
Loading... -
+
OA03.01 - Session Introduction
14:30 - 14:31 | Presenter: Andrew Ciupek
- Abstract
Loading... -
+
OA03.02 - Session Introduction
14:31 - 14:32 | Presenter: David R. Gandara
- Abstract
Loading... -
+
OA03.03 - Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors
14:32 - 14:42 | Presenter: Gerald Falchook
- Abstract
Loading... -
+
OA03.04 - Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
14:42 - 14:52 | Presenter: Adrian Sacher
- Abstract
Loading... -
+
OA03.05 - Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Primary Analysis of the Confirmatory VISION Cohort C
14:52 - 15:02 | Presenter: Michael Thomas
- Abstract
Loading... -
+
OA03.06 - CodeBreaK 100/101: First Report of Safety/Efficacy of Sotorasib in Combination with Pembrolizumab or Atezolizumab in Advanced KRAS p.G12C NSCLC
15:02 - 15:12 | Presenter: Bob T. Li
- Abstract
Loading... -
+
OA03.07 - Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial
15:12 - 15:22 | Presenter: Shun Lu
- Abstract
Loading... -
+
OA03.08 - Discussant
15:22 - 15:32 | Presenter: Helena Linardou
- Abstract
Loading... -
+
OA03.09 - Live Q&A
15:32 - 15:40
- Abstract
Loading...
-
+
P1.09 - Global Health, Health Services Research, and Health Economics - Support to Patients and Staff
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Global Health, Health Services Research, and Health Economics - Support to Patients and Staff
-
+
P1.09-01 - The Lung Cancer Patient Experience and Care Pathway: A Multi-Country Survey
Presenter: Pauline Frank- Abstract
Loading...
-
+
P1.12 - Management of Lung Cancer in the Era of COVID-19
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Management of Lung Cancer in the Era of COVID-19
-
+
P1.12-01 - Lung Cancer Screening in the COVID-19 Era: Understanding Program-Level Impact
Presenter: Andrew Ciupek- Abstract
Loading...
-
+
P2.08 - Patient Advocacy
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Patient Advocacy
-
+
P2.08-01 - Real-world barriers to clinical trial enrollment as reported by U.S. lung cancer patients and community cancer centers
Presenter: Andrew Ciupek- Abstract
Loading...
